US equities |
MU $896.07 ▼-0.98% SPCX $147.79 ▼-0.11% NVDA $216.47 ▼-0.29% AAPL $339.50 ▼-1.00% TSLA $373.71 ▲+1.54% META $694.25 ▼-1.59% AMZN $262.63 ▲+0.07% SNDK $1,365.38 ▼-0.42%
FinancialContent

Articles published by Lobe Sciences Ltd.

News headline image
Lobe Sciences Appoints Tracy L. Goeken, M.D., as Chief Medical Officer
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Appoints Annette Grimaldi, Former Head of Life Sciences Investment Banking at BMO Capital Markets, to Board of Directors
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Announces Proposed Capital Markets Initiatives to Support Planned Growth
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Expands Leadership Team with New CFO Appointment
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Reports Third Quarter 2026 Financial Results
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Ltd. Announces Non-Brokered Private Placement
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Announces Results of Annual General and Special Meeting of Shareholders
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Files Management Information Circular for Annual General and Special Meeting on July 30, 2026
From Lobe Sciences Ltd.
Via ACCESS Newswire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Announces Update
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Provides Company Review of 2023
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Provides Update on L-130 Clinical Program
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia™ & Company
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Initiates Phase 1 Clinical Trial of L-130
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia™
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF